Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Perrigo Company (PRGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 11,291,860
  • Shares Outstanding, K 142,610
  • Annual Sales, $ 5,281 M
  • Annual Income, $ -4,012,800 K
  • 36-Month Beta 0.69
  • Price/Sales 2.10
  • Price/Cash Flow 9.61
  • Price/Book 1.83

Price Performance

See More
Period Period Low Period High Performance
1-Month
63.68 +22.30%
on 08/09/17
80.00 -2.65%
on 08/10/17
+4.01 (+5.43%)
since 07/17/17
3-Month
63.68 +22.30%
on 08/09/17
80.00 -2.65%
on 08/10/17
+4.81 (+6.58%)
since 05/17/17
52-Week
63.68 +22.30%
on 08/09/17
99.14 -21.44%
on 09/23/16
-11.66 (-13.02%)
since 08/17/16

Most Recent Stories

More News
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Endo Internation (ENDP, LCI, SUPN, TXMD, PRGO)

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

LCI : 15.45 (-3.74%)
ENDP : 8.62 (-0.92%)
SUPN : 44.40 (-2.74%)
TXMD : 6.16 (+3.70%)
PRGO : 77.82 (-1.72%)
Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog® II Cream

Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application referencing Mycolog®...

PRGO : 77.82 (-1.72%)
The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion's, Zynerba and Valeant

The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion's, Zynerba and Valeant

ESPR : 45.50 (-5.82%)
MYL : 30.48 (+0.03%)
ZYNE : 6.26 (-1.57%)
VRX : 14.38 (+1.63%)
PRGO : 77.82 (-1.72%)
Company News For August 11, 2017

Companies in the new are: PRGO,KSS,EAT,LYV

LYV : 39.12 (-1.58%)
EAT : 34.55 (-1.43%)
KSS : 37.37 (-1.37%)
PRGO : 77.82 (-1.72%)
Pharma Stock Roundup: Mylan Misses, Perrigo Tops in Q2, Zynerba Plunges on Study Failure

This week, focus was on earnings announcements from companies like Mylan (MYL), Perrigo and Endo.

ESPR : 45.50 (-5.82%)
MYL : 30.48 (+0.03%)
MRK : 62.01 (-1.10%)
ZYNE : 6.26 (-1.57%)
VRX : 14.38 (+1.63%)
BMY : 56.95 (-0.96%)
PRGO : 77.82 (-1.72%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (PRGO, IPXL, DEPO, NEOS, TXMD)

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

IPXL : 18.10 (-2.43%)
TXMD : 6.16 (+3.70%)
PRGO : 77.82 (-1.72%)
DEPO : 6.34 (+3.43%)
NEOS : 6.78 (+1.19%)
Perrigo (PRGO) Q2 Earnings & Sales Top, 2017 View Raised

Perrigo (PRGO) posts better-than-expected results with revenue beating estimates. The company also ups its earnings outlook, courtesy a continued positive execution across all business segments.

ENZ : 11.00 (-0.72%)
SMMT : 12.77 (+1.92%)
ADRO : 11.10 (-1.77%)
PRGO : 77.82 (-1.72%)
Perrigo Company plc Reports Second Quarter 2017 Financial Results

-- Delivered second quarter 2017 GAAP ("reported") net sales of $1.2 billion

PRGO : 77.82 (-1.72%)
Watch for Perrigo Co Plc to Potentially Rebound After Falling 1.61% Yesterday

Perrigo Co Plc (NASDAQ:PRGO) traded in a range yesterday that spanned from a low of $63.68 to a high of $65.99. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $66.24...

PRGO : 77.82 (-1.72%)
Perrigo Company (PRGO) Q2 Earnings: What's in the Cards?

Perrigo's (PRGO) Rx segment is likely to continue hurting the company's performance. However, product acquisitions and new product launches in the same might boost sales in the coming quarters.

ESPR : 45.50 (-5.82%)
ZTS : 61.24 (-0.42%)
TSRO : 108.54 (-3.94%)
PRGO : 77.82 (-1.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United...

See More

Support & Resistance

2nd Resistance Point 80.15
1st Resistance Point 79.67
Last Price 77.69
1st Support Level 78.29
2nd Support Level 77.39

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.